158 related articles for article (PubMed ID: 1773587)
1. Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography.
Baglin TP; Crocker J; Timmins A; Chandler S; Boughton BJ
Clin Lab Haematol; 1991; 13(4):341-8. PubMed ID: 1773587
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study.
Lisse I; Hasselbalch H; Junker P
APMIS; 1991 Feb; 99(2):171-8. PubMed ID: 2001283
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.
Kvasnicka HM; Thiele J
Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769
[TBL] [Abstract][Full Text] [Related]
5. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
Zhang B; Lewis SM
Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
[TBL] [Abstract][Full Text] [Related]
6. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
7. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
Buhr T; Georgii A; Choritz H
Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
Nagao T; Yonekura S
Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
[No Abstract] [Full Text] [Related]
9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
10. [Vascular changes in bone marrow in blood diseases].
Demmler K; Burkhardt R
Med Klin; 1980 Apr; 75(9):328-32. PubMed ID: 7402170
[No Abstract] [Full Text] [Related]
11. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
Tovar-Bobadilla JL; Ortiz-Hidalgo C
Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
13. Increased vascularity of bone marrow in myelofibrosis.
Charbord P
Br J Haematol; 1986 Mar; 62(3):595-6. PubMed ID: 3954970
[No Abstract] [Full Text] [Related]
14. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
15. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow.
Thiele J; Rompcik V; Wagner S; Fischer R
Br J Haematol; 1992 Feb; 80(2):227-34. PubMed ID: 1550781
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide imaging of bone marrow.
Fordham EW; Ali A
Semin Hematol; 1981 Jul; 18(3):222-39. PubMed ID: 7280717
[No Abstract] [Full Text] [Related]
18. [Occurrence of myelofibrosis in individual types of chronic myeloproliferative diseases].
Adamkov M; Plank L; Szépe P
Bratisl Lek Listy; 1998 May; 99(5):240-4. PubMed ID: 9673037
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow lymphoid nodules in myeloproliferative disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance.
Cervantes F; Pereira A; Marti JM; Feliu E; Rozman C
Br J Haematol; 1988 Nov; 70(3):279-82. PubMed ID: 3207625
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
